Birchview Capital, LP - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$727,000
+238.1%
30,150
+170.4%
0.38%
+220.8%
Q1 2017$215,000
+25.0%
11,1500.0%0.12%
+13.2%
Q4 2016$172,000
+18.6%
11,1500.0%0.11%
+24.7%
Q3 2016$145,000
-6.5%
11,1500.0%0.08%
-24.8%
Q2 2016$155,00011,1500.11%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders